The Fertility Show, London, 3-4 November 2018
Page URL: https://www.bionews.org.uk/page_93317

Pioneering clinical trial using cardiac stem cells shows early promise

21 November 2011
Appeared in BioNews 634

The world's first clinical trial using patients' own cardiac stem cells to repair heart damage has produced surprising results. The preliminary trial was designed simply to test the safety of the procedure, but doctors observed an unexpected improvement in heart function in patients receiving the treatment. 

Professor Roberto Bolli, the lead researcher from the University of Louisville in the US, said: 'The results are striking. If these results hold up in future studies, I believe this could be the biggest revolution in cardiovascular medicine in my lifetime'.

The trial included 14 patients that were undergoing heart bypass surgery following a heart attack. During the surgery a section of tissue from a healthy region of the heart was removed and the cardiac stem cells extracted. The cells were cultured in a dish until there were around a million of them before being injected back into the heart. 

Four months after the injection, the average heart function of the 14 patients (measured as the percentage of blood pumped out of the heart with every beat) had risen from 30.3 percent before treatment to 38.5 percent. There were also reductions in tissue damage and patients reported improvements in their quality of life. Seven control patients who did not receive the stem cell injection did not show any improvement.

Professor Bolli said: 'We believe these findings are very significant. Our results indicate that cardiac stem cells can markedly improve the contractile function of the heart'.

This is the first human trial to use stem cells from a patient's own heart tissue to repair damage. Several studies have previously shown that stem cells derived from bone marrow can have a similar effect on heart function, and trials using these cells are at a much more advanced stage.

However Professor Bolli believes that using cardiac stem cells is preferable as 'their natural function is to replace the cells that continuously die in the heart due to wear and tear'. 

Professor Peter Weissberg, medical director at the British Heart Foundation added: 'Unlike many previous studies, this research has used cells derived from the patients' own hearts, rather than from blood or bone marrow. Their preliminary findings, in a small number of patients, showed a modest improvement in heart function - this is similar to those reported in other cell therapy studies'.

'This is positive, but the crucial next steps are to see whether this improvement is confirmed in the final completed trial, and to understand whether the cells are actually replacing damaged heart cells or are secreting molecules that are helping to heal the heart'.

The research was conducted in conjunction with Harvard Medical School and is published in The Lancet.

SOURCES & REFERENCES
Cardiac cells 'heal heart damage'
BBC News |  14 November 2011
Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial
The Lancet |  14 November 2011
Heart repair with stem cells 'biggest breakthrough in a generation'
Daily Telegraph |  15 November 2011
Stem cells may aid heart repair
NHS Choices - Behind the Headlines |  15 November 2011
Stem Cells Repair Heart in First-Ever Study
WebMD |  14 November 2011
RELATED ARTICLES FROM THE BIONEWS ARCHIVE
12 November 2012 - by Dr Anna Cauldwell 
Eight heart attack patients given injections of stem cells harvested from their own hearts show significant improvement in their heart function two years after treatment...
5 March 2012 - by Cathy Holding 
A major clinical trial to investigate a stem cell treatment for chronic ischemic heart disease (IHD) – a leading cause of death around the world – has begun in the US...
20 February 2012 - by Cathy Holding 
A stem cell-based therapy aiming to reverse the damage caused by heart attacks has shown positive results in an early clinical trial...
12 December 2011 - by Victoria Kay 
The world's first 'clinical grade' human embryonic stem cells have been donated to the UK Stem Cell Bank (UKSCB). The high quality cell lines are expected to become the gold standard for developing new cell-based therapies for serious medical conditions, including spinal cord injuries...
5 December 2011 - by Dr Louisa Petchey 
Research in mice has shown the heart contains its own renewable source of stem cells which can differentiate into a variety of cell types. The research team in Australia hopes that one day the stem cells could be activated so a broken heart can be made to mend itself....
12 September 2011 - by Rosie Beauchamp 
An Australian company has announced it has received regulatory approval from the European Medicines Agency (EMA) to begin phase II trials for its cardiovascular stem cell treatment, Revascor....
18 July 2011 - by Dr Sarah Spain 
Researchers at Northwestern University, Chicago, USA, have reported that the injection of stem cells into heart tissue can significantly improve the symptoms of those with severe angina. They found that exercise tolerance was increased and the number of pain episodes was halved, compared to those not given the injections....
13 June 2011 - by Dr Sophie Pryor 
A naturally occurring protein can activate stem cells in mouse hearts, producing new muscle cells to replace the tissue damaged by a heart attack, UK scientists have found...
4 May 2010 - by Ruth Pidsley 
Stem cells have been successfully extracted from veins left over from heart bypass surgery. Scientists hope that such cells could be used in the treatment of future heart conditions by stimulating the growth of new arteries...
27 November 2006 - by Heidi Nicholl 
US scientists have discovered 'cardiac master cells' that are able to transform into any of the three main forms of heart tissue. The heart has long been thought of as unable to regenerate itself when damaged. This research gives hope that therapies may be developed, possibly using...
HAVE YOUR SAY
Log in to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions


Syndicate this story - click here to enquire about using this story.